News Experts in Transplantation, Engineered Cells and Pediatrics Join Growing Roswell Park Cell Therapy Program
News Roswell Park Study First to Show Two-Drug Combination Selectively Targets p53-Mutant Cancers Leads to Clinical Study in Refractory GI Cancers
Video A Comprehensive Overview of Tumor-Infiltrating Lymphocyte (TIL) Therapy for Metastatic Melanoma